4.5 Article

Exercise prevents obesity-induced cognitive decline and white matter damage in mice

Journal

NEUROBIOLOGY OF AGING
Volume 80, Issue -, Pages 154-172

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2019.03.018

Keywords

Aging; Brain Health; Obesity; Neuroinflammation; Cerebrovascular Health; Exercise

Funding

  1. The Jane B. Cook Foundation
  2. The Jackson Laboratory Nathan Shock Center of Excellence in the Basic Biology of Aging, National Institute on Aging [K01 AG049050, P30 AG10133, R01 AG19771]
  3. Alzheimer's Association
  4. Indiana University HealtheIndiana University School of Medicine Strategic Research Initiative
  5. Indiana Clinical and Translational Science Institute (CTSI)
  6. Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant) [U01 AG024904]
  7. DOD ADNI (Department of Defense) [W81XWH-12-2-0012]
  8. National Institute on Aging
  9. AbbVie
  10. Alzheimer's Drug Discovery Foundation
  11. Araclon Biotech
  12. BioClinica, Inc
  13. Biogen
  14. Bristol-Myers Squibb Company
  15. CereSpir, Inc
  16. Cogstate
  17. Eisai Inc
  18. Elan Pharmaceuticals, Inc
  19. Eli Lilly and Company
  20. Euroimmun
  21. F. Hoffmann-La Roche Ltd
  22. Genentech, Inc
  23. Fujirebio
  24. GE Healthcare
  25. IXICO Ltd
  26. Janssen Alzheimer Immunotherapy Research & Development, LLC.
  27. Johnson & Johnson Pharmaceutical Research & Development LLC.
  28. Lumosity
  29. Lundbeck
  30. Merck Co, Inc
  31. Meso Scale Diagnostics, LLC.
  32. NeuroRx Research
  33. Neurotrack Technologies
  34. Novartis Pharmaceuticals Corporation
  35. Pfizer Inc
  36. Piramal Imaging
  37. Servier
  38. Takeda Pharmaceutical Company
  39. Transition Therapeutics
  40. Canadian Institutes of Health Research
  41. National Institute of Biomedical Imaging and Bioengineering
  42. Northern California Institute for Research and Education
  43. [RF1AG051496]

Ask authors/readers for more resources

Obesity in the western world has reached epidemic proportions, and yet the long-term effects on brain health are not well understood. To address this, we performed transcriptional profiling of brain regions from a mouse model of western diet (WD)-induced obesity. Both the cortex and hippocampus from C57BL/6J (B6) mice fed either a WD or a control diet from 2 months of age to 12 months of age (equivalent to midlife in a human population) were profiled. Gene set enrichment analyses predicted that genes involved in myelin generation, inflammation, and cerebrovascular health were differentially expressed in brains from WD-fed compared to control diet-fed mice. White matter damage and cerebrovascular decline were evident in brains from WD-fed mice using immunofluorescence and electron microscopy. At the cellular level, the WD caused an increase in the numbers of oligodendrocytes and myeloid cells suggesting that a WD is perturbing myelin turnover. Encouragingly, cerebrovascular damage and white matter damage were prevented by exercising WD-fed mice despite mice still gaining a significant amount of weight. Collectively, these data show that chronic consumption of a WD in B6 mice causes obesity, neuroinflammation, and cerebrovascular and white matter damage, but these potentially damaging effects can be prevented by modifiable risk factors such as exercise. (C) 2019 The Authors. Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available